Latest Recce Pharmaceuticals (ASX:RCE) News
Page 5
Page 5 of 5
Recce Pharmaceuticals Expands Patent Reach into China’s $4B Antibiotic Market
26 May 2025
Recce Pharmaceuticals Secures A$8.4M to Propel Phase 3 Trials for Synthetic Antibiotics
16 May 2025
Recce Pharmaceuticals Advances with 93% Efficacy in Phase II and $15.8M Capital Raise
30 Apr 2025
Recce Pharmaceuticals Hits 93% Efficacy in Phase II Trial of RECCE® 327 Gel
17 Feb 2025
Recce Pharmaceuticals Halts Trading Ahead of Key Announcement
13 Feb 2025
Recce Pharmaceuticals Advances Phase 3 Trial and Secures A$6.75m R&D Rebate
31 Jan 2025
Recce Pharmaceuticals Advances RECCE® 327 with Promising Phase II Topical Gel Results
21 Jan 2025